Tandem Diabetes Care’s new CEO inherits a growing $1bn business. Can she deliver profitability?
Tandem Diabetes Care names Jeannette Bankes CEO amid 14% sales growth. Examine her strategy, $10 million equity award and profitability outlook.
Pharma & Biotech
Medical Devices & Diagnostics
Abbott’s Libre Duo gets FDA authorization as continuous glucose monitoring expands into ketone detection
Abbott’s Libre Duo 10 Day has received FDA De Novo authorization as the first integrated continuous glucose and ketone monitoring system in the United States, potentially extending CGM from daily glucose control into early diabetic ketoacidosis warning.
Medical Devices & Diagnostics
Abbott TactiFlex Duo keeps 92.6% of AFib patients free of documented recurrence in standard monitoring
Abbott’s investigational TactiFlex Duo dual-energy ablation catheter delivered favorable 12-month results in the FlexPulse Global IDE study, supporting the company’s effort to secure U.S. FDA approval after receiving CE Mark in Europe.
Medical Devices & Diagnostics
FDA authorizes Abbott Libre Duo as first continuous glucose-ketone wearable
Libre Duo 10 Day continuously measures glucose and ketones every minute for people with diabetes aged two and older, creating the first US integrated glucose-ketone monitoring category.
Medical Devices & Diagnostics
Why Abbott’s Ultreon 3.0 could reshape stent planning in complex coronary disease
AI can now guide coronary imaging in real time. Abbott’s Ultreon 3.0 puts precision PCI closer to routine clinical workflow.
Medical Devices & Diagnostics
Medtronic’s MiniMed Go cleared by FDA: Can smart MDI finally close the algorithm gap in diabetes care?
Medtronic’s MiniMed Go earns FDA clearance. Learn how it could reshape insulin injection therapy by combining smart pens, CGM insights, and dose algorithms.
Medical Devices & Diagnostics
Can Medtronic and Abbott redefine insulin delivery with the Instinct-integrated MiniMed 780G?
Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.